0.3300
0.0000
(0.00%)
At close: January 10 at 4:27:05 PM GMT
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APTA.L | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Related Tickers
ALT1.MX Altimmune, Inc.
148.05
0.00%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
3G0.F Altimmune, Inc.
6.73
-5.92%
7IZ.MU Ziccum AB
0.0298
-29.72%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
41X.F Ardelyx, Inc.
5.12
+0.16%
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
CXF.F Chimerix, Inc.
3.1350
-6.00%
BLE.BE bluebird bio Inc
0.3708
-3.01%